08:25 AM EST, 12/30/2024 (MT Newswires) -- Polyrizon ( PLRZ ) announced Monday the publication of its national phase patent application with the US Patent and Trademark Office.

The application covers its core nasal technologies: capture and contain, a blocker system, and trap and target, designed for advanced drug delivery.

US patent applications are generally published after 18 months from the date of filing.

Shares of the company jumped more than 60% in recent premarket activity.